Stocks › OPK
OPKO HEALTH, INC.
OPK·Nasdaq·
United States·USD
$1.57
-0.04 (-2.48%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
OPK
OPKO HEALTH, INC. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
OPKS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of OPK by members of U.S. Congress · 3 on record
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
Carlos CurbeloHouse · R · FL |
OPKOPKO HEALTH, INC. · Stock |
Purchase $1,001 - $15,000 |
Oct 3, 2017 | Sep 26, 2017 | Filing ↗ |
Carlos Mr CurbeloHouse · R · FL |
OPKOPKO HEALTH, INC. · Stock |
Purchase $1,001 - $15,000 |
Mar 2, 2017 | Mar 2, 2017 | Filing ↗ |
Carlos Mr CurbeloHouse · R · FL |
OPKOPKO HEALTH, INC. · Stock |
Purchase $1,001 - $15,000 |
Feb 7, 2017 | Feb 7, 2017 | Filing ↗ |
Whale Activity
Position changes in OPK reported for 2026-09-30 by 247 institutional filers
- Increased53
- New28
- Held65
- Decreased69
- Closed22
- No prior filing10
| Filer | Shares | Value | Change |
|---|---|---|---|
| Rubric Capital Management LP | 47.8M | $76.9M | held |
| BlackRock, Inc. | 36.8M | $59.3M | decreased |
| VANGUARD CAPITAL MANAGEMENT LLC | 14.8M | $23.9M | decreased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 14.7M | $23.6M | decreased |
| GEODE CAPITAL MANAGEMENT, LLC | 11.1M | $17.8M | decreased |
| STATE STREET CORP | 10.7M | $17.2M | increased |
| GOLDMAN SACHS GROUP INC | 8.0M | $12.9M | increased |
| Whitefort Capital Management, LP | 4.7M | $7.6M | increased |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 3.8M | $6.1M | increased |
| NORTHERN TRUST CORP | 3.7M | $5.9M | decreased |
| UBS Group AG | 2.9M | $4.7M | decreased |
| CITADEL ADVISORS LLC | 2.8M | $4.5M | increased |
Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.
Insider Trading
Net shares bought (+) or sold (−) on the open market by OPK insiders, by quarter · Form 4
Recent Insider Transactions
10,003 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| PAGANELLI JOHN ADirector · Director | Sale | −9,175 | $1.82 | $17K | Nov 5, 2026 | Form 4 ↗ |
| PAGANELLI JOHN ADirector · Director | Sale | −4,426 | $1.78 | $8K | Nov 5, 2026 | Form 4 ↗ |
| Logal AdamSr. Vice President, CFO | Tax withholding | −53.3K | $1.22 | $65K | Jul 24, 2026 | Form 4 ↗ |
| Rubin Steven DExecutive VP-Administration · Director | Tax withholding | −53.3K | $1.22 | $65K | Jul 24, 2026 | Form 4 ↗ |
| PAGANELLI JOHN ADirector | Purchase | +10.0K | $1.14 | $11K | Mar 20, 2026 | Form 4 ↗ |
| Frost Gamma Investments Trust10% owner | Purchase | +192.9K | $1.34 | $258K | Nov 21, 2025 | Form 4 ↗ |
| Frost Gamma Investments Trust10% owner | Purchase | +191.5K | $1.33 | $255K | Nov 21, 2025 | Form 4 ↗ |
| Frost Gamma Investments Trust10% owner | Purchase | +89.4K | $1.33 | $119K | Nov 21, 2025 | Form 4 ↗ |
| Frost Gamma Investments Trust10% owner | Purchase | +3,894 | $1.32 | $5K | Nov 21, 2025 | Form 4 ↗ |
| Frost Gamma Investments Trust10% owner | Purchase | +102.4K | $1.30 | $133K | Nov 21, 2025 | Form 4 ↗ |
| Frost Gamma Investments Trust10% owner | Purchase | +13.7K | $1.35 | $18K | Nov 20, 2025 | Form 4 ↗ |
| Frost Gamma Investments Trust10% owner | Purchase | +1,757 | $1.35 | $2K | Nov 20, 2025 | Form 4 ↗ |
| Frost Gamma Investments Trust10% owner | Purchase | +24.6K | $1.34 | $33K | Nov 20, 2025 | Form 4 ↗ |
| Frost Gamma Investments Trust10% owner | Purchase | +161.8K | $1.34 | $217K | Nov 20, 2025 | Form 4 ↗ |
| Frost Gamma Investments Trust10% owner | Purchase | +211.9K | $1.33 | $282K | Nov 20, 2025 | Form 4 ↗ |
| Frost Gamma Investments Trust10% owner | Purchase | +47.1K | $1.33 | $63K | Nov 20, 2025 | Form 4 ↗ |
| Frost Gamma Investments Trust10% owner | Purchase | +119.1K | $1.32 | $157K | Nov 20, 2025 | Form 4 ↗ |
| Frost Gamma Investments Trust10% owner | Purchase | +155.5K | $1.32 | $205K | Nov 19, 2025 | Form 4 ↗ |
| Frost Gamma Investments Trust10% owner | Purchase | +198.9K | $1.32 | $263K | Nov 19, 2025 | Form 4 ↗ |
| Frost Gamma Investments Trust10% owner | Purchase | +66.5K | $1.31 | $87K | Nov 19, 2025 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding OPK · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| iShares Russell 2000 ETF iShares Trust | 10.5M | $15.7M | 0.02% | Jun 30, 2026 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 9.8M | $14.6M | 0.00% | Jun 30, 2026 |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 6.9M | $10.4M | 0.01% | Jun 30, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 4.9M | $7.4M | 0.01% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 4.4M | $5.7M | 0.02% | Jul 31, 2026 |
| iShares Russell 2000 Value ETF iShares Trust | 3.8M | $5.7M | 0.04% | Jun 30, 2026 |
| iShares Biotechnology ETF iShares Trust | 2.7M | $4.0M | 0.04% | Jun 30, 2026 |
| VANGUARD RUSSELL 2000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 2.3M | $3.4M | 0.02% | Aug 31, 2026 |
| VANGUARD SMALL-CAP VALUE INDEX FUND VANGUARD INDEX FUNDS | 2.2M | $3.3M | 0.00% | Jun 30, 2026 |
| VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS | 2.0M | $3.0M | 0.01% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list OPK's shares (CUSIP 68375N103), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming opko health as client
- GOTHAM GOVERNMENT RELATIONSOPKO HEALTH, INC. · 2026 Q3 · HCR$45K
Filing ↗ - GOTHAM GOVERNMENT RELATIONSOPKO HEALTH, INC. · 2026 Q2 · HCR, MED, PHA$45K
Filing ↗ - GOTHAM GOVERNMENT RELATIONSOPKO HEALTH, INC. · 2026 Q1 · HCR$23K
Filing ↗ - GOTHAM GOVERNMENT RELATIONSOPKO HEALTH, INC. · 2026 Q1 · HCR, PHA—
Filing ↗ - CYRUS M. JOLLIVETTE PUBLIC AFFAIRS LLCOPKO HEALTH, INC. · 2016 Q3 · HCR$25K
Filing ↗
Government Contracts
Federal awards to OPKO HEALTH, INC. · USAspending
No federal contract awards found for OPKO HEALTH, INC..
U.S. Patents
Recent USPTO applications naming OPKO HEALTH, INC.
No USPTO patent applications found for OPKO HEALTH, INC..
Annual Financials
From OPK's 10-K filings · XBRL
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $606.9M | $713.1M | $863.5M | $1.00B | $1.77B |
| Operating income | -$117.4M | -$152.1M | -$157.0M | -$226.3M | $18.8M |
| Net income | -$225.7M | -$53.2M | -$188.9M | -$328.4M | -$30.1M |
| Diluted EPS | -$0.30 | -$0.08 | -$0.25 | -$0.46 | -$0.05 |
| Operating cash flow | -$178.5M | -$183.5M | -$28.2M | -$95.2M | $38.3M |
| Cash and equivalents | $364.4M | $426.6M | $95.9M | $153.2M | $134.7M |
| Total assets | $1.93B | $2.20B | $2.01B | $2.17B | $2.40B |
| Total liabilities | $664.0M | $834.8M | $622.5M | $605.6M | $714.6M |
| Shareholders' equity | $1.27B | $1.37B | $1.39B | $1.56B | $1.69B |
As OPKO HEALTH, INC. tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 26, 2026 ↗
Stock Splits
Every split and reverse split in the price history
No stock splits in OPK's price history.
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 2.02, 9.01Results of operationsNov 4, 2026
EDGAR ↗ - 8-K · Items 1.01, 9.01Material agreementOct 15, 2026
EDGAR ↗ - 8-K · Items 8.01Other eventsOct 2, 2026
EDGAR ↗ - 8-K · Items 1.01, 2.03, 9.01Material agreement · Direct financial obligationAug 14, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsJul 27, 2026
EDGAR ↗ - 8-K · Items 5.07Shareholder voteJun 18, 2026
EDGAR ↗
About OPKO HEALTH, INC.
From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersMIAMI, FL
IncorporatedDE
SEC CIK0000944809 ↗
Former namesEXEGENICS INC, eXegenics Inc, CYTOCLONAL PHARMACEUTICS INC /DE

